Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

HAMDY MOHTASEB

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1164423257
CMS profile
52517
Location
BULLHEAD CITY, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2022 · Entire year

$4,754.19

84 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2022 · entire year · sorted by reported total

By paying entity

PY2022 · entire year · sorted by reported total

Page 2 of 2; records 51–84 of 84 matching records. This page contains 34 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

HAMDY MOHTASEB

NPI 1164423257 · CMS profile ID 52517

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

BULLHEAD CITY, AZ

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 2; records 51–84 of 84 matching records. This page contains 34 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1164423257?year=2022&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
HAMDY MOHTASEB, NPI 1164423257, CMS profile ID 52517. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–84 of 84 matching records. This page contains 34 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1164423257?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
APA 7
IndustryPayments. (2026). HAMDY MOHTASEB, NPI 1164423257, CMS profile ID 52517. General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 2; records 51–84 of 84 matching records. This page contains 34 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1164423257?year=2022&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c.
Bluebook
HAMDY MOHTASEB, NPI 1164423257, CMS profile ID 52517, IndustryPayments, General Payments, PY2022; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 2; records 51–84 of 84 matching records. This page contains 34 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/df01c2f8-dc1f-4e79-96cb-8208beaf143c. https://industrypayments.org/provider/npi-1164423257?year=2022&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2022

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2022 · Physicians and non-physician practitioners · CMS publication 2026-06-30

84 matching records · $4,754.19 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 84 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–84 of 84.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
EISAI INC. $21.5206/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 908040145 CMS
Novartis Pharmaceuticals Corporation $83.3306/15/2022 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893986279 CMS
Janssen Biotech, Inc. $16.2906/08/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885497119 CMS
Amgen Inc. $18.6106/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 940006953 CMS
Merck Sharp & Dohme LLC $19.2106/02/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944336635 CMS
Genentech USA, Inc. $21.5305/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 950773741 CMS
Incyte Corporation $16.3005/26/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942987969 CMS
Adaptive Biotechnologies Corporation $18.8305/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951434979 CMS
Bayer HealthCare Pharmaceuticals Inc. $17.2905/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 930603699 CMS
Novartis Pharmaceuticals Corporation $7.8505/24/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893986271 CMS
Incyte Corporation $15.9805/19/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942987961 CMS
EMD Serono, Inc. $14.1305/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941515077 CMS
Novartis Pharmaceuticals Corporation $83.3305/16/2022 Long term medical supply or device loan No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 893986277 CMS
AMAG Pharmaceuticals, Inc. $14.2605/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 953401857 CMS
Adaptive Biotechnologies Corporation $24.8205/10/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 951434975 CMS
Myovant Sciences Inc. $23.8805/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 941226047 CMS
Merck Sharp & Dohme LLC $17.8205/03/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 944157781 CMS
Janssen Biotech, Inc. $22.2404/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885497099 CMS
Pharmacyclics LLC, an AbbVie Company $15.3904/12/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 890344379 CMS
Janssen Biotech, Inc. $10.0004/06/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885497091 CMS
AMAG Pharmaceuticals, Inc. $13.1304/05/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 953401859 CMS
E.R. Squibb & Sons, L.L.C. $24.8003/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932636225 CMS
Janssen Biotech, Inc. $13.4203/29/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885497115 CMS
Janssen Biotech, Inc. $15.7603/23/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885497087 CMS
TerSera Therapeutics LLC $13.7703/01/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 943240337 CMS
AMAG Pharmaceuticals, Inc. $12.9902/21/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 953401861 CMS
Janssen Biotech, Inc. $12.5302/15/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885497127 CMS
Regeneron Healthcare Solutions, Inc. $18.3702/11/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 927289109 CMS
Celgene Corporation $17.5302/07/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932636211 CMS
Incyte Corporation $12.0001/31/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942987899 CMS
Incyte Corporation $27.5601/27/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 942987895 CMS
Amgen Inc. $21.3501/25/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 939604471 CMS
Janssen Biotech, Inc. $26.8901/17/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 885497123 CMS
Celgene Corporation $13.9601/04/2022 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 932636193 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $885.39 41
PY2020 $2,081.17 77
PY2021 $2,189.97 66
PY2022 $4,754.19 84
PY2023 $2,046.30 86
PY2024 $2,625.78 104
PY2025 $2,245.82 102

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $7,400.80 5
PY2024 Principal investigator $44,975.70 3

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

5 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 Epizyme, Inc. $62.80 11/12/2025 Non-covered Recipient Entity
Mohtaseb Cancer Center And Blood Disorders
Symphony-1: A Phase 1b/3 Double-Blind, Randomized, Active-Controlled, 3-Stage, Biomarker Adaptive Study Of Tazemetostat Or Placebo In Combination With Lenalidomide Plus Rituximab In Subjects With Relapsed/Refractory Follicular Lymphoma No dispute reported 06/30/2026 1184285072
Principal investigator 1 Epizyme, Inc. $78.00 11/12/2025 Non-covered Recipient Entity
Mohtaseb Cancer Center And Blood Disorders
Symphony-1: A Phase 1b/3 Double-Blind, Randomized, Active-Controlled, 3-Stage, Biomarker Adaptive Study Of Tazemetostat Or Placebo In Combination With Lenalidomide Plus Rituximab In Subjects With Relapsed/Refractory Follicular Lymphoma No dispute reported 06/30/2026 1184285074
Principal investigator 1 Epizyme, Inc. $2,760.00 07/14/2025 Non-covered Recipient Entity
Mohtaseb Cancer Center And Blood Disorders
Symphony-1: A Phase 1b/3 Double-Blind, Randomized, Active-Controlled, 3-Stage, Biomarker Adaptive Study Of Tazemetostat Or Placebo In Combination With Lenalidomide Plus Rituximab In Subjects With Relapsed/Refractory Follicular Lymphoma No dispute reported 06/30/2026 1184285070
Principal investigator 1 SANOFI US SERVICES INC. $3,000.00 04/02/2025 Non-covered Recipient Entity
Sargon Research
A Randomized, Phase 3, Open Label Study Evaluating Subcutaneous Versus Intravenous Administration of Isatuximab in Combination With Pomalidomide and Dexamethasone in Adult Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) No dispute reported 06/30/2026 1226130834
Principal investigator 1 SANOFI US SERVICES INC. $1,500.00 01/13/2025 Non-covered Recipient Entity
Sargon Research
A Randomized, Phase 3, Open Label Study Evaluating Subcutaneous Versus Intravenous Administration of Isatuximab in Combination With Pomalidomide and Dexamethasone in Adult Patients With Relapsed and/or Refractory Multiple Myeloma (RRMM) No dispute reported 06/30/2026 1226130839